MedTrace Logo

Prognostic Factors and Outcomes of COVID-19 Cases in Ethiopia

NCT04584424 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6390

Last updated 2024-09-19

No results posted yet for this study

Summary

The aim of the study will be to determine the epidemiological and clinical features of COVID-19 cases, immunological and virological courses, interaction with nutritional status, and response to treatment for COVID-19 patients admitted to treatment centers in Ethiopia.

Methods: This multi-site cohort enrolls, patients with confirmed COVID-19 infection admitted to treatment centers will be enrolled irrespective of their symptoms and followed up for 12 months. Baseline epidemiological, clinical, laboratory and imaging data will be collected from treatment records, interviews, physical measurements and biological samples. Endline data involves treatment and prognostic outcomes to be measured using different biomarkers and clinical parameters, The patients will be followed up in the selected treatment centers for COVID-19 infection. For all data collected both descriptive and multivariable analyses will be performed to isolated determinants of the treatment outcome and prognosis to generate relevant information for informed prevention and case management.

Conditions

  • Epidemiology
  • Clinical
  • Nutritional-status
  • Immunologic Defect

Interventions

OTHER

The study does not required

The study is prospective multi-center COVID-19 patient cohort

Sponsors & Collaborators

  • Ethiopian Public Health Institute

    lead OTHER_GOV

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-30
Primary Completion
2022-11-14
Completion
2022-11-14

Countries

  • Ethiopia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04584424 on ClinicalTrials.gov